Tafluprost for the Reduction of Interocular Pressure in Open Angle Glaucoma and Ocular Hypertension
Tafluprost is an FP receptor antagonist that has been shown in clinical studies in Europe and Japan to be extremely useful in treating elevated intraocular pressure and glaucoma. The drug is well tolerated and appears to be at least equal in effectiveness and perhaps superior to other protanoids for...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2011-01-01
|
| Series: | Ophthalmology and Eye Diseases |
| Online Access: | https://doi.org/10.4137/OED.S4253 |
| _version_ | 1811268870597509120 |
|---|---|
| author | Clyde Schultz |
| author_facet | Clyde Schultz |
| author_sort | Clyde Schultz |
| collection | DOAJ |
| description | Tafluprost is an FP receptor antagonist that has been shown in clinical studies in Europe and Japan to be extremely useful in treating elevated intraocular pressure and glaucoma. The drug is well tolerated and appears to be at least equal in effectiveness and perhaps superior to other protanoids for routine use comparison to be superior to other treatments for the elevated IOP as the side effects and other related symptomology appear to be less, while maintaining a level of pressure control for prolonged periods. |
| first_indexed | 2024-04-12T21:30:42Z |
| format | Article |
| id | doaj.art-ee6293d3939e4fd1a856c46913fd5cb3 |
| institution | Directory Open Access Journal |
| issn | 1179-1721 |
| language | English |
| last_indexed | 2024-04-12T21:30:42Z |
| publishDate | 2011-01-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Ophthalmology and Eye Diseases |
| spelling | doaj.art-ee6293d3939e4fd1a856c46913fd5cb32022-12-22T03:16:03ZengSAGE PublishingOphthalmology and Eye Diseases1179-17212011-01-01310.4137/OED.S4253Tafluprost for the Reduction of Interocular Pressure in Open Angle Glaucoma and Ocular HypertensionClyde Schultz0Department of Biology, University of Calgary, Calgary, Alberta Canada T2N 1N4 and Biogram Inc., Ponte Vedra Beach, FL 32004, USA.Tafluprost is an FP receptor antagonist that has been shown in clinical studies in Europe and Japan to be extremely useful in treating elevated intraocular pressure and glaucoma. The drug is well tolerated and appears to be at least equal in effectiveness and perhaps superior to other protanoids for routine use comparison to be superior to other treatments for the elevated IOP as the side effects and other related symptomology appear to be less, while maintaining a level of pressure control for prolonged periods.https://doi.org/10.4137/OED.S4253 |
| spellingShingle | Clyde Schultz Tafluprost for the Reduction of Interocular Pressure in Open Angle Glaucoma and Ocular Hypertension Ophthalmology and Eye Diseases |
| title | Tafluprost for the Reduction of Interocular Pressure in Open Angle Glaucoma and Ocular Hypertension |
| title_full | Tafluprost for the Reduction of Interocular Pressure in Open Angle Glaucoma and Ocular Hypertension |
| title_fullStr | Tafluprost for the Reduction of Interocular Pressure in Open Angle Glaucoma and Ocular Hypertension |
| title_full_unstemmed | Tafluprost for the Reduction of Interocular Pressure in Open Angle Glaucoma and Ocular Hypertension |
| title_short | Tafluprost for the Reduction of Interocular Pressure in Open Angle Glaucoma and Ocular Hypertension |
| title_sort | tafluprost for the reduction of interocular pressure in open angle glaucoma and ocular hypertension |
| url | https://doi.org/10.4137/OED.S4253 |
| work_keys_str_mv | AT clydeschultz tafluprostforthereductionofinterocularpressureinopenangleglaucomaandocularhypertension |